Bft Financial Group »

ImmunoGen shares owned by Bft Financial Group

Quarter-by-quarter ownership of ImmunoGen shares owned by Bft Financial Group from 13F filings

Historical chart of Bft Financial Group investment in ImmunoGen

Tip: Access up to 7 years of quarterly data

All positions including ImmunoGen held by Bft Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ImmunoGen by Bft Financial Group

Quarter filed Position value Share count Share price at filing
2023-06-30 $472k 25k 18.87
2023-03-31 $96k 25k 3.84
2022-03-31 $119k 25k 4.76

More positions owned by Bft Financial Group

Johnson & Johnson (JNJ)
American Centy Etf Tr Us Eqt Etf (AVUS)
Vanguard World Esg Us Stk Etf (ESGV)
Apple (AAPL)
Vanguard World Esg Intl Stk Etf (VSGX)
Amazon (AMZN)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Affirm Hldgs Com Cl A (AFRM)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Ishares U S Etf Tr Int Rt Hdg C B (LQDH)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Sba Communications Corp Cl A (SBAC)
Invesco Qqq Tr Unit Ser 1 (QQQ)
J P Morgan Exchange Traded F Ultra Shrt Inc (JPST)
Microsoft Corporation (MSFT)

View all positions for Bft Financial Group

Top funds holding ImmunoGen

Wellington Management Company
Healthcare Of Ontario Pension Plan Trust Fund
Alliancebernstein
venBio Select Advisor
Decheng Capital
Hsbc Holdings
PRIMECAP Management Company
Allianz Asset Management
DLD Asset Management
Nicholas Investments Partners
MetLife Investment Advisors
American International
Guggenheim Capital, LLC Managers
Angelo, Gordon & Co
Kellner Capital

View all funds holding ImmunoGen